Filing Details

Accession Number:
0001209191-19-062039
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-27 17:49:36
Reporting Period:
2019-12-24
Accepted Time:
2019-12-27 17:49:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1142596 Nuvasive Inc NUVA Surgical & Medical Instruments & Apparatus (3841) 330768598
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1565950 Matthew Link 7475 Lusk Blvd.
San Diego CA 92121
President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-11-20 695 $0.00 82,448 No 5 G Direct
Common Stock Disposition 2019-12-24 3,500 $77.38 78,948 No 4 S Direct
Common Stock Acquisiton 2019-12-24 12,500 $44.24 91,448 No 4 M Direct
Common Stock Acquisiton 2019-12-24 260 $26.62 91,708 No 4 M Direct
Common Stock Disposition 2019-12-24 8,672 $77.70 83,081 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2019-12-24 12,500 $0.00 12,500 $44.24
Common Stock Employee Stock Option (Right to Buy) Disposition 2019-12-24 260 $0.00 260 $26.62
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-04-01 No 4 M Direct
0 2021-01-03 No 4 M Direct
Footnotes
  1. Represents a gift of 695 shares.
  2. Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Company equity awards.
  3. Sales effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1.
  4. Weighted average sales price from sales transactions ranging from $77.15 to $77.61. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
  5. Payment of exercise price and tax liability by Issuer's withholding of shares incident to the respective option exercise.
  6. These stock options, representing a right to purchase a total of 12,500 shares, were granted on April 1, 2010 and are fully vested.
  7. These stock options, representing a right to purchase a total of 260 shares, were granted on January 3, 2011 and are fully vested.